Last reviewed · How we verify
Systane (r) Ultra
Systane Ultra is a lubricating eye drop that provides sustained moisture and relief to the ocular surface by forming a protective film.
Systane Ultra is a lubricating eye drop that provides sustained moisture and relief to the ocular surface by forming a protective film. Used for Dry eye syndrome / dry eye disease.
At a glance
| Generic name | Systane (r) Ultra |
|---|---|
| Also known as | Systane Ultra |
| Sponsor | ORA, Inc. |
| Drug class | Artificial tear / ocular lubricant |
| Modality | Small molecule |
| Therapeutic area | Ophthalmology |
| Phase | FDA-approved |
Mechanism of action
Systane Ultra contains a proprietary blend of lubricants including polyethylene glycol 400 and propylene glycol, along with the gelling agent hydroxypropyl guar, which creates a sustained-release formulation. The formula adheres to the eye surface and provides long-lasting lubrication and protection for dry eye symptoms. It works through mechanical hydration and surface protection rather than targeting a specific molecular receptor.
Approved indications
- Dry eye syndrome / dry eye disease
Common side effects
- Eye irritation
- Blurred vision
- Ocular discomfort
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Systane (r) Ultra CI brief — competitive landscape report
- Systane (r) Ultra updates RSS · CI watch RSS
- ORA, Inc. portfolio CI